Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma

Journal of Pathology

Volumn 211, Issue 3, 2007, Pages 305-313

  Barth, T F E ^a   Barth, C A ^a   Kestler, H A ^a   Michl, P ^a   Weniger, M A ^a   Buchholz, M ^a   Möller, Peter ^a   Gress, T ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

cDNA array; Expression profiling; Gastrointestinal lymphoma

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA TUBULIN; CATHEPSIN B; CELL CYCLE PROTEIN; CHORIONIC GONADOTROPIN RECEPTOR; COLLAGEN TYPE 3; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 1; DEOXYRIBONUCLEASE I; DIHYDROFOLATE REDUCTASE; DIPEPTIDYL PEPTIDASE I; DNA TOPOISOMERASE (ATP HYDROLYSING); FIBRONECTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTEGRIN LINKED KINASE; LUTEINIZING HORMONE; MYC PROTEIN; PROTEASOME; RAS PROTEIN; RIBONUCLEOTIDE REDUCTASE; RNA; SYNDECAN 1; UBIQUITIN CONJUGATING ENZYME; UROKINASE;

ACCURACY; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; CELL ISOLATION; CHROMOSOME 11Q; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; FROZEN SECTION; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; LASER MICRODISSECTION; LYMPHOCYTOMA; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH LYMPHOMA;

GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, SMALL-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 33846644490     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2096     Document Type: Article

References (41)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-1416.
2. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nature Rev Cancer 2004;4:644-653.
3. Cavalli F, Isaacson PG, Gascoyne RD, Zucca E. MALT lymphomas. Hematology (Am Soc Hematol Educ Program) 2001;1:241-258.
4. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol 1990;136:1153-1164.
5. Peng H, Du M, Diss TC, Isaacson PG, Pan L. Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 1997;30:425-429.
6. Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E, et al. Molecular analysis of the progression from Helicobacter Pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804-810.
7. Cabras AD, Candidus S, Fend F, Kremer M, Schulz S, Bordi C, et al. Biclonality of gastric lymphomas. Lab Invest. 2001;81:961-967.
8. Cabras AD, Weirich G, Fend F, Nahrig J, Bordi C, Holler H, et al. Oligoclonality of a 'composite' gastric diffuse large B-cell lymphoma with areas of marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Virchows Arch 2002;440:209-214.
9. Harris NL, Isaacson PG. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Am J Clin Pathol 1999;111:S126-S132.
10. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997. Hematol J 2000;1:53-66.
11. Jaffe ES, Harris NL, Stein H. Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissue. IARC Press: Lyon, 2001.
12. Isaacson PG. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999;10:637-645.
13. Barth TF, Bentz M, Leithauser F, Stilgenbauer S, Siebert R, Schlotter M, et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001;31:316-325.
14. Barth TF, Dohner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M, et al. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood 1998;91:4321-4330.
15. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868.
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121.
17. Storey JD, Tibshirani R. Statistical significance for genome-wide studies. Proc Natl Acad Sci U S A 2003;100:9440-9445.
18. Holger Schwender 2006; siggenes: SAM and Efron's Empirical Bayes Approaches R Package Version 1.6.0. url: http://www.bio-conductor.org.
19. R: A Language and Environment for Statistical Computing [computer program]. Version. R Foundation for Statistical Computing: Vienna, 2005. url: http://www.R-project.org.
20. Barth TFEMS, Pawlita M, Siebert R, Rother JU, Mechtersheimer G, Kitinya J, et al. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement. J Pathol 2004;203:940-945.
21. Arends JE, Bot FJ, Gisbertz IA, Schouten HC. Expression of CD10, CD75 and CD43 in MALT lymphoma and their usefulness in discriminating MALT lymphoma from follicular lymphoma and chronic gastritis. Histopathology 1999;35:209-215.
22. Korkolopoulou P, Oates J, Kittas C, Crocker J. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol 1994;47:9-14.
23. Krugmann J, Dirnhofer S, Gschwendtner A, Berresheim U, Greil R, Krugmann K, et al. Primary gastrointestinal B-cell lymphoma. A clinicopathological and immunohistochemical study of 61 cases with an evaluation of prognostic parameters. Pathol Res Pract 2001;197:385-393.
24. Hazar B, Polat G, Seyrek E, Bagdatoglglu O, Kanik A, Tiftik N. Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in Hodgkin's and non-Hodgkin's lymphoma. Int J Clin Pract 2004;58:139-143.
25. Sakata K, Satoh M, Someya M, Asanuma H, Nagakura H, Oouchi A, et al. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer 2004;100:356-365.
26. Banerjee SK, Weston A-P, Zoubine MN, Campbell DR, Cherian R. Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma: relationship to cell death, proliferation, and transformation. Am J Pathol 2000;156:217-225.
27. Jin YH, Park CK. Expression of cyclin B1 and cdc2 in nodal non-Hodgkin's lymphoma and its prognostic implications. J Korean Med Sci 2002;17:322-327.
28. Duensing S, Munger K. Centrosome abnormalities and genomic instability induced by human papillomavirus oncoproteins. Prog Cell Cycle Res 2003;5:383-391.
29. Nanjangud G, Rao PH, Hegde A, Teruya-Feldstein J, Donnelly G, Qin J, et al. Spectral karyotyping identifies new rearrangements, translocations, and clinical associations in diffuse large B-cell lymphoma. Blood 2002;99:2554-2561.
30. Glasova M, Konikova E, Stasakova J, Babusikova O. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells. Neoplasma 1998;45:88-95.
31. Rossi A, Deveraux Q, Turk B, Sali A. Comprehensive search for cysteine cathepsins in the human genome. Biol Chem 2004;385:363-372.
32. Kayser K, Richter N, Hufnagl P, Kayser G, Kos J, Werle B. Expression, proliferation activity and clinical significance of cathepsin B and cathepsin L in operated lung cancer. Anticancer Res 2003;23:2767-2772.
33. Lah TT, Kalman E, Najar D, Gorodetsky E, Brennan P, Somers R, et al. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis. Hum Pathol 2000;31:149-160.
34. Talieri M, Papadopoulou S, Scorilas A, Xynopoulos D, Arnogianaki N, Plataniotis G, et al. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett 2004;205:97-106.
35. al Sarireh B, Eremin O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinburgh 2000;45:1-16.
36. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-265.
37. Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenefic and morphologic features. Blood 1996;87:299-307.
38. Hoeve MA, Gisbertz IA, Schouten HC, Schuuring E, Bot FJ, Hermans J, et al. Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia 1999;13:799-807.
39. Ott G, Kalla J, Steinhoff A, Rosenwald A, Katzenberger T, Roblick U, et al. Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol 1998;153:689-694.
40. Starostik P, Greiner A, Schultz A, Zettl A, Peters K, Rosenwald A, et al. Genetic aberrations common in gastric high-grade large B-cell lymphoma. Blood 2000;95:1180-1187.
41. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-2004.